The cognitive effects of adjuvant chemotherapy in early stage breast cancer: A prospective study

Psycho-Oncology

Volumn 17, Issue 2, 2008, Pages 122-130

  Stewart, Angela ^a   Collins, Barbara ^b   Mackenzie, Joyce ^b   Tomiak, Eva ^c   Verma, Shailendra ^d   Bielajew, Catherine ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Adjuvant chemotherapy; Adjuvant hormonal treatment; Breast cancer; Cognitive function; Oncology

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE DERIVATIVE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; LETROZOLE; PACLITAXEL; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER STAGING; COGNITION; CONTROLLED STUDY; DEPRESSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY CANCER; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; POSTMENOPAUSE; PROSPECTIVE STUDY; SCORING SYSTEM; SIDE EFFECT; WORKING MEMORY;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; EDUCATIONAL STATUS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEUROPSYCHOLOGICAL TESTS; POSTMENOPAUSE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 39549083876     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1210     Document Type: Article

References (53)

1. Ahles TA, Tope DM, Furstenberg C, Hann D, Mills L. Psychologic and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol 1996;14:1457-1462.
2. Ahles TA, Saykin AJ, Furstenberg T et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002;20:485-493.
3. Bender CM, Sereika SM, Berga SL et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology 2006;15:422-430.
4. Brezden C, Phillips K-A, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000;18: 2695-2701.
5. Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 2004;26: 955-969.
6. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 2005; 104: 2499-2507.
7. Fan HG, Houede-Tchen Yi, Chemerynsky I, Downie FP, Sabate K, Tannock IF. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 2005; 23:8025-8032.
8. Gottschalk LA, Holcombe RF, Jackson D, Bechtel RJ. The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients. Method Find Exp Clin Pharmacol 2003;25:117-122.
9. Hurria A, Rosen C, Hudis et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 2006; 54:925-931.
10. Jenkins V, Shilling V, Deutsch G et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006;94:829-834.
11. Schagen SB, van Dam FSAM, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Am Cancer Soc 1999;85:640-650.
12. Schagen SB, Muller MJ, Boogerd W et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 2002;132:1387-1397.
13. Scherwath A, Mehnart A, Schleimer B et al. Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Ann Oncol 2006;17:415-423.
14. Servaes P, Verhagen CAHHVM, Bleijenberg G. Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior. Cancer 2002;95:2017-2026.
15. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D. The effects of adjuvant chemotherapy on cognition in women with breast cancer-preliminary results of an observational longitudinal study. Breast 2005;14: 142-150.
16. Tchen N, Juffs HG, Downie FP et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003;21:4175-4183.
17. van Dam FSAM, Schagen SB, Muller MJ et al. impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210-218.
18. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer 2004;100:2292-2299.
19. Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 1995;4:61-66.
20. Meyers CA, Byrne KS, Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 1995;12:231-235.
21. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. 'Chemobrain' in breast carcinoma? A prologue. Cancer 2004; 101:466-475.
22. Howieson DB, Loring DW, Hannay HJ. Neurobehavioral variables and diagnostic issues. In Neuropsychological Assessment (4th edn), Lezak et al. (ed.). Oxford University Press: Oxford, 2004; 286-336.
23. Eberling JL, Wu C, Tong-Turnbeaugh R, Jajust WJ. Estrogen- and tamoxifen-associated effects on brain structure and function. NeuroImage 2004;21:364-371.
24. Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A metaanalysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006; 20:76-89.
25. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips K-A. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a metaanalysis of the current literature. Brain Cognition 2005;59:60-70.
26. Cohen J. Statistical Power Analysis for the Behavioural Sciences (2nd edn). Lawrence Erlbaum Associates, Inc.: Hillsdale, NJ, 1988.
27. Ammons RB, Ammons CH. The Quick Test (QT): Provisional Manual. Psychological Reports (Monograph Supplement I-VII), 1962; 111-161.
28. McNair DM, Lorr M, Droppleman LF. Manual for the Profile of Mood States. Educational and Industrial Service: San Diego, CA, 1992.
29. Woods SP, Childers M, Ellis RJ, Guaman S, Grant I, Heaton RK. A battery approach for measuring neuropsychological change. Arch Clin Neuropsychol 2006;21:83-89.
30. Gronwall DMA. Paced Auditory Serial Addition Task. A measure of recovery from concussion. Percept Motor Skill 1977;44:367-373.
31. Army Individual Test Battery. Manual for Directions and Scoring. War Department, Adjutant General's Office: Washington, DC, 1944.
32. Heaton RK. Wisconsin Card Sorting Test Manual. Psychological Assessment Resources: Odessa, FL, 1981.
33. Goodglass H, Kaplan E, Weintraub S. The Boston Naming Test (2nd edn). Lea & Febiger: Philadelphia, 1983.
34. Benton AL, Hamsher K, Sivan AB. Multilingual Aphasia Examination (3rd edn). AJA: Iowa City, IA, 1994.
35. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Neuropsychology Press: Tucson, AZ, 1985.
36. Wechsler D. Wechsler Adult Intelligence Scale (3rd edn). Harcourt, Brace, & Co: San Antonio, TX, 1997.
37. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test II Manual. The Psychological Corporation: San Antonio, TX, 2000.
38. Wechsler D. Wechsler Memory Scale (3rd edn). Harcourt, Brace, & Co: San Antonio, TX, 1997.
39. Rey A. Epreuves mnesiques et d'apprentissage. Delachaux & Nestle: Lausanne, 1968.
40. Brown J. Some tests of the decay theory of immediate memory. Quart J Exp Psychol 1958;10:12-21.
41. McSweeney AJ, Naugle RI, Chelune GC, Luders H. 'T scores for change': an illustration of a regression approach to depicting change in clinical neuropsychology. Clin Neuropsychol 1993;7:300-312.
42. Sawrie SM, Marson DC, Boothe AL, Harrell LE. A method for assessing clinically relevant individual cognitive change in older adult populations. J Gerontol Psychol Sci 1999;54B:116-124.
43. Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psycho-Oncology 2004; 13: 61-66.
44. Paganini-Hill A, Clark LJ. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 2000;64:165-176.
45. Shilling V, Jenkins V, Fallowfield L, Howell T. The effects of hormone therapy on cognition in breast cancer. J Steroid Biochem Mol Biol 2003;86:405-412.
46. Anderson-Hanley C, Sherman ML, Riggs R, Agocha B, Compas BE. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 2003;9:967-982.
47. Shilling V, Jenkins V, Trapala IS. The (mis)classification of chemo-fog - methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 2006; 95:125-129.
48. Barth JT, Macciocchi SN, Giordani B et al. Neuropsychological sequelae of minor head injury. Neurosurgery 1983; 13:529-533.
49. Mendez MF Cummings JL. Dementia: A Clinical Approach (3rd edn). Elsevier: Philadelphia, 2003; 339-342.
50. Hannay HJ, Howieson DB, Loring DW. Neuropathology for neuropsychologists. In Neuropsychological Assessment (4th edn), Lezak et al. (eds). Oxford University Press: Oxford, 2004; 157-285.
51. Saykin AJ, Ahles TA, McDonald BC. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Sem Clin Neuropsychiatry 2003; 8:201-216.
52. Saykin A, McDonald B, Ahles T et al. Altered brain activation following systemic chemotherapy for breast cancer: interim analysis from a prospective fMRI study. Presented at the 34th Annual Meeting of the International Neuropsychological Society, Boston, MA, 1-4 February 2006.
53. Stern Y. What is cognitive reserve? Theory and research applications of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460.